Global Cannabinoid-based Antitumor Drug Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cannabinoid-based Antitumor Drug Market Size 2017-2028

2.1.2 Cannabinoid-based Antitumor Drug Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Cannabinoid-based Antitumor Drug Segment by Type

2.2.1 Chewing Medicine

2.2.2 Lozenge

2.2.3 Other

2.3 Cannabinoid-based Antitumor Drug Market Size by Type

2.3.1 Cannabinoid-based Antitumor Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Cannabinoid-based Antitumor Drug Market Size Market Share by Type (2017-2022)

2.4 Cannabinoid-based Antitumor Drug Segment by Application

2.4.1 Clinics

2.4.2 Hospitals

2.4.3 Others

2.5 Cannabinoid-based Antitumor Drug Market Size by Application

2.5.1 Cannabinoid-based Antitumor Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Cannabinoid-based Antitumor Drug Market Size Market Share by Application (2017-2022)

3 Cannabinoid-based Antitumor Drug Market Size by Player

3.1 Cannabinoid-based Antitumor Drug Market Size Market Share by Players

3.1.1 Global Cannabinoid-based Antitumor Drug Revenue by Players (2020-2022)

3.1.2 Global Cannabinoid-based Antitumor Drug Revenue Market Share by Players (2020-2022)

3.2 Global Cannabinoid-based Antitumor Drug Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Cannabinoid-based Antitumor Drug by Regions

4.1 Cannabinoid-based Antitumor Drug Market Size by Regions (2017-2022)

4.2 Americas Cannabinoid-based Antitumor Drug Market Size Growth (2017-2022)

4.3 APAC Cannabinoid-based Antitumor Drug Market Size Growth (2017-2022)

4.4 Europe Cannabinoid-based Antitumor Drug Market Size Growth (2017-2022)

4.5 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size Growth (2017-2022)

5 Americas

5.1 Americas Cannabinoid-based Antitumor Drug Market Size by Country (2017-2022)

5.2 Americas Cannabinoid-based Antitumor Drug Market Size by Type (2017-2022)

5.3 Americas Cannabinoid-based Antitumor Drug Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cannabinoid-based Antitumor Drug Market Size by Region (2017-2022)

6.2 APAC Cannabinoid-based Antitumor Drug Market Size by Type (2017-2022)

6.3 APAC Cannabinoid-based Antitumor Drug Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Cannabinoid-based Antitumor Drug by Country (2017-2022)

7.2 Europe Cannabinoid-based Antitumor Drug Market Size by Type (2017-2022)

7.3 Europe Cannabinoid-based Antitumor Drug Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cannabinoid-based Antitumor Drug by Region (2017-2022)

8.2 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Type (2017-2022)

8.3 Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Cannabinoid-based Antitumor Drug Market Forecast

10.1 Global Cannabinoid-based Antitumor Drug Forecast by Regions (2023-2028)

10.1.1 Global Cannabinoid-based Antitumor Drug Forecast by Regions (2023-2028)

10.1.2 Americas Cannabinoid-based Antitumor Drug Forecast

10.1.3 APAC Cannabinoid-based Antitumor Drug Forecast

10.1.4 Europe Cannabinoid-based Antitumor Drug Forecast

10.1.5 Middle East & Africa Cannabinoid-based Antitumor Drug Forecast

10.2 Americas Cannabinoid-based Antitumor Drug Forecast by Country (2023-2028)

10.2.1 United States Cannabinoid-based Antitumor Drug Market Forecast

10.2.2 Canada Cannabinoid-based Antitumor Drug Market Forecast

10.2.3 Mexico Cannabinoid-based Antitumor Drug Market Forecast

10.2.4 Brazil Cannabinoid-based Antitumor Drug Market Forecast

10.3 APAC Cannabinoid-based Antitumor Drug Forecast by Region (2023-2028)

10.3.1 China Cannabinoid-based Antitumor Drug Market Forecast

10.3.2 Japan Cannabinoid-based Antitumor Drug Market Forecast

10.3.3 Korea Cannabinoid-based Antitumor Drug Market Forecast

10.3.4 Southeast Asia Cannabinoid-based Antitumor Drug Market Forecast

10.3.5 India Cannabinoid-based Antitumor Drug Market Forecast

10.3.6 Australia Cannabinoid-based Antitumor Drug Market Forecast

10.4 Europe Cannabinoid-based Antitumor Drug Forecast by Country (2023-2028)

10.4.1 Germany Cannabinoid-based Antitumor Drug Market Forecast

10.4.2 France Cannabinoid-based Antitumor Drug Market Forecast

10.4.3 UK Cannabinoid-based Antitumor Drug Market Forecast

10.4.4 Italy Cannabinoid-based Antitumor Drug Market Forecast

10.4.5 Russia Cannabinoid-based Antitumor Drug Market Forecast

10.5 Middle East & Africa Cannabinoid-based Antitumor Drug Forecast by Region (2023-2028)

10.5.1 Egypt Cannabinoid-based Antitumor Drug Market Forecast

10.5.2 South Africa Cannabinoid-based Antitumor Drug Market Forecast

10.5.3 Israel Cannabinoid-based Antitumor Drug Market Forecast

10.5.4 Turkey Cannabinoid-based Antitumor Drug Market Forecast

10.5.5 GCC Countries Cannabinoid-based Antitumor Drug Market Forecast

10.6 Global Cannabinoid-based Antitumor Drug Forecast by Type (2023-2028)

10.7 Global Cannabinoid-based Antitumor Drug Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Cannabics Inc.

11.1.1 Cannabics Inc. Company Information

11.1.2 Cannabics Inc. Cannabinoid-based Antitumor Drug Product Offered

11.1.3 Cannabics Inc. Cannabinoid-based Antitumor Drug Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Cannabics Inc. Main Business Overview

11.1.5 Cannabics Inc. Latest Developments

11.2 Tikun Olam

11.2.1 Tikun Olam Company Information

11.2.2 Tikun Olam Cannabinoid-based Antitumor Drug Product Offered

11.2.3 Tikun Olam Cannabinoid-based Antitumor Drug Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Tikun Olam Main Business Overview

11.2.5 Tikun Olam Latest Developments

11.3 Jay Pharma

11.3.1 Jay Pharma Company Information

11.3.2 Jay Pharma Cannabinoid-based Antitumor Drug Product Offered

11.3.3 Jay Pharma Cannabinoid-based Antitumor Drug Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Jay Pharma Main Business Overview

11.3.5 Jay Pharma Latest Developments

11.4 GW Pharmaceuticals

11.4.1 GW Pharmaceuticals Company Information

11.4.2 GW Pharmaceuticals Cannabinoid-based Antitumor Drug Product Offered

11.4.3 GW Pharmaceuticals Cannabinoid-based Antitumor Drug Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 GW Pharmaceuticals Main Business Overview

11.4.5 GW Pharmaceuticals Latest Developments

11.5 Medicanja Ltd

11.5.1 Medicanja Ltd Company Information

11.5.2 Medicanja Ltd Cannabinoid-based Antitumor Drug Product Offered

11.5.3 Medicanja Ltd Cannabinoid-based Antitumor Drug Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Medicanja Ltd Main Business Overview

11.5.5 Medicanja Ltd Latest Developments

11.6 Valeant Pharmaceuticals

11.6.1 Valeant Pharmaceuticals Company Information

11.6.2 Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Product Offered

11.6.3 Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Valeant Pharmaceuticals Main Business Overview

11.6.5 Valeant Pharmaceuticals Latest Developments

12 Research Findings and Conclusion

Table 1. Cannabinoid-based Antitumor Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Chewing Medicine

Table 3. Major Players of Lozenge

Table 4. Major Players of Other

Table 5. Cannabinoid-based Antitumor Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Cannabinoid-based Antitumor Drug Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Cannabinoid-based Antitumor Drug Market Size Market Share by Type (2017-2022)

Table 8. Cannabinoid-based Antitumor Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Cannabinoid-based Antitumor Drug Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Cannabinoid-based Antitumor Drug Market Size Market Share by Application (2017-2022)

Table 11. Global Cannabinoid-based Antitumor Drug Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Player (2020-2022)

Table 13. Cannabinoid-based Antitumor Drug Key Players Head office and Products Offered

Table 14. Cannabinoid-based Antitumor Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Cannabinoid-based Antitumor Drug Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Cannabinoid-based Antitumor Drug Market Size Market Share by Regions (2017-2022)

Table 19. Americas Cannabinoid-based Antitumor Drug Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Cannabinoid-based Antitumor Drug Market Size Market Share by Country (2017-2022)

Table 21. Americas Cannabinoid-based Antitumor Drug Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Cannabinoid-based Antitumor Drug Market Size Market Share by Type (2017-2022)

Table 23. Americas Cannabinoid-based Antitumor Drug Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Cannabinoid-based Antitumor Drug Market Size Market Share by Application (2017-2022)

Table 25. APAC Cannabinoid-based Antitumor Drug Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Cannabinoid-based Antitumor Drug Market Size Market Share by Region (2017-2022)

Table 27. APAC Cannabinoid-based Antitumor Drug Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Cannabinoid-based Antitumor Drug Market Size Market Share by Type (2017-2022)

Table 29. APAC Cannabinoid-based Antitumor Drug Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Cannabinoid-based Antitumor Drug Market Size Market Share by Application (2017-2022)

Table 31. Europe Cannabinoid-based Antitumor Drug Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Cannabinoid-based Antitumor Drug Market Size Market Share by Country (2017-2022)

Table 33. Europe Cannabinoid-based Antitumor Drug Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Cannabinoid-based Antitumor Drug Market Size Market Share by Type (2017-2022)

Table 35. Europe Cannabinoid-based Antitumor Drug Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Cannabinoid-based Antitumor Drug Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Cannabinoid-based Antitumor Drug Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Cannabinoid-based Antitumor Drug Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Cannabinoid-based Antitumor Drug Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Cannabinoid-based Antitumor Drug

Table 44. Key Market Challenges & Risks of Cannabinoid-based Antitumor Drug

Table 45. Key Industry Trends of Cannabinoid-based Antitumor Drug

Table 46. Global Cannabinoid-based Antitumor Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Cannabinoid-based Antitumor Drug Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Cannabinoid-based Antitumor Drug Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Cannabinoid-based Antitumor Drug Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Cannabinoid-based Antitumor Drug Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Cannabinoid-based Antitumor Drug Market Size Market Share Forecast by Application (2023-2028)

Table 52. Cannabics Inc. Details, Company Type, Cannabinoid-based Antitumor Drug Area Served and Its Competitors

Table 53. Cannabics Inc. Cannabinoid-based Antitumor Drug Product Offered

Table 54. Cannabics Inc. Cannabinoid-based Antitumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Cannabics Inc. Main Business

Table 56. Cannabics Inc. Latest Developments

Table 57. Tikun Olam Details, Company Type, Cannabinoid-based Antitumor Drug Area Served and Its Competitors

Table 58. Tikun Olam Cannabinoid-based Antitumor Drug Product Offered

Table 59. Tikun Olam Main Business

Table 60. Tikun Olam Cannabinoid-based Antitumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Tikun Olam Latest Developments

Table 62. Jay Pharma Details, Company Type, Cannabinoid-based Antitumor Drug Area Served and Its Competitors

Table 63. Jay Pharma Cannabinoid-based Antitumor Drug Product Offered

Table 64. Jay Pharma Main Business

Table 65. Jay Pharma Cannabinoid-based Antitumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Jay Pharma Latest Developments

Table 67. GW Pharmaceuticals Details, Company Type, Cannabinoid-based Antitumor Drug Area Served and Its Competitors

Table 68. GW Pharmaceuticals Cannabinoid-based Antitumor Drug Product Offered

Table 69. GW Pharmaceuticals Main Business

Table 70. GW Pharmaceuticals Cannabinoid-based Antitumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. GW Pharmaceuticals Latest Developments

Table 72. Medicanja Ltd Details, Company Type, Cannabinoid-based Antitumor Drug Area Served and Its Competitors

Table 73. Medicanja Ltd Cannabinoid-based Antitumor Drug Product Offered

Table 74. Medicanja Ltd Main Business

Table 75. Medicanja Ltd Cannabinoid-based Antitumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Medicanja Ltd Latest Developments

Table 77. Valeant Pharmaceuticals Details, Company Type, Cannabinoid-based Antitumor Drug Area Served and Its Competitors

Table 78. Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Product Offered

Table 79. Valeant Pharmaceuticals Main Business

Table 80. Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Valeant Pharmaceuticals Latest Developments

List of Figures

Figure 1. Cannabinoid-based Antitumor Drug Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Cannabinoid-based Antitumor Drug Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Cannabinoid-based Antitumor Drug Market Size Market Share by Type in 2021

Figure 7. Cannabinoid-based Antitumor Drug in Clinics

Figure 8. Global Cannabinoid-based Antitumor Drug Market: Clinics (2017-2022) & ($ Millions)

Figure 9. Cannabinoid-based Antitumor Drug in Hospitals

Figure 10. Global Cannabinoid-based Antitumor Drug Market: Hospitals (2017-2022) & ($ Millions)

Figure 11. Cannabinoid-based Antitumor Drug in Others

Figure 12. Global Cannabinoid-based Antitumor Drug Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Cannabinoid-based Antitumor Drug Market Size Market Share by Application in 2021

Figure 14. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Player in 2021

Figure 15. Global Cannabinoid-based Antitumor Drug Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Cannabinoid-based Antitumor Drug Market Size 2017-2022 ($ Millions)

Figure 17. APAC Cannabinoid-based Antitumor Drug Market Size 2017-2022 ($ Millions)

Figure 18. Europe Cannabinoid-based Antitumor Drug Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Cannabinoid-based Antitumor Drug Market Size 2017-2022 ($ Millions)

Figure 20. Americas Cannabinoid-based Antitumor Drug Value Market Share by Country in 2021

Figure 21. Americas Cannabinoid-based Antitumor Drug Consumption Market Share by Type in 2021

Figure 22. Americas Cannabinoid-based Antitumor Drug Market Size Market Share by Application in 2021

Figure 23. United States Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Cannabinoid-based Antitumor Drug Market Size Market Share by Region in 2021

Figure 28. APAC Cannabinoid-based Antitumor Drug Market Size Market Share by Application in 2021

Figure 29. China Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Cannabinoid-based Antitumor Drug Market Size Market Share by Country in 2021

Figure 36. Europe Cannabinoid-based Antitumor Drug Market Size Market Share by Type in 2021

Figure 37. Europe Cannabinoid-based Antitumor Drug Market Size Market Share by Application in 2021

Figure 38. Germany Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Cannabinoid-based Antitumor Drug Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Cannabinoid-based Antitumor Drug Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Cannabinoid-based Antitumor Drug Market Size Market Share by Application in 2021

Figure 46. Egypt Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Cannabinoid-based Antitumor Drug Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 52. APAC Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 53. Europe Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 55. United States Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 56. Canada Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 59. China Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 60. Japan Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 61. Korea Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 63. India Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 64. Australia Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 65. Germany Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 66. France Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 67. UK Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 68. Italy Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 69. Russia Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 70. Spain Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 73. Israel Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Cannabinoid-based Antitumor Drug Market Size 2023-2028 ($ Millions)